ArticleTransboundary and emerging diseases2026
ORF3 Depletion Attenuates SADS-CoV Virulence and Retains Partial Maternally Mediated Protection in Suckling Mice.
Article in Transboundary and emerging diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging enteric coronavirus that causes severe diarrhea and high mortality in neonatal piglets. Its broad host range, tropism for human-origin cells, and limited vaccine availability underscore the importance of defining viral determinants of pathogenicity. The accessory protein ORF3 has been linked to CoV virulence, but its role in SADS-CoV infection in vivo and its impact on maternally transferred protection have not been fully established. Here, we used reverse genetics to generate rSADS-ΔORF3/GFP, a recombinant virus with ORF3 replaced by GFP, and compared it with parental rSADS-CoV in suckling BALB/c mice. ORF3 depletion markedly attenuated disease and reduced viral RNA burdens across tissues relative to parental rSADS-CoV. Because maternally derived immunity is critical to protection against swine enteric CoV infection in newborn animals, we further evaluated whether rSADS-ΔORF3/GFP, as a potential live attenuated vaccine (LAV), could elicit maternal protection transferred from inoculated dams to their offspring. Compared with parental rSADS-CoV, rSADS-ΔORF3/GFP induced lower maternal neutralizing antibody titers and provided less robust protection in challenged offspring. Nevertheless, offspring from rSADS-ΔORF3/GFP-inoculated dams showed improved survival, weight gain, milder intestinal pathology, and lower tissue viral RNA burdens than offspring from DMEM-inoculated dams, indicating retained protective immunogenicity. Together, these findings support a contribution of ORF3 to SADS-CoV virulence and demonstrate that ORF3 depletion yields an attenuated virus that retains partial maternally mediated protective efficacy. The residual immunogenicity of rSADS-ΔORF3/GFP, combined with its reduced virulence, supports its further evaluation as a LAV candidate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.